HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ASCC1
activating signal cointegrator 1 complex subunit 1
Chromosome 10 Β· 10q22.1
NCBI Gene: 51008Ensembl: ENSG00000138303.19HGNC: HGNC:24268UniProt: A0A5F9ZH79
67PubMed Papers
22Diseases
0Drugs
30Pathogenic Variants
FUNCTIONAL ROLE
DNA RepairTranscription Factor
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
regulation of DNA-templated transcriptionprotein bindingnucleustranscription regulator complexspinal muscular atrophy with congenital bone fractures 2spinal muscular atrophyarthrogryposisHypotonia
✦AI Summary

ASCC1 (activating signal cointegrator 1 complex subunit 1) is a multifunctional nuclear protein combining a K-Homology RNA-binding domain with a two-histidine phosphodiesterase domain 1. As a component of the ASC-1 transcriptional coregulator complex, ASCC1 enhances transactivation by NF-ΞΊB, SRF, and AP1 transcription factors 2. The ASC-1 complex disassembles collided ribosomes during ribosome-associated quality control in an ATP-dependent, ubiquitination-dependent manner 3. ASCC1 also participates in DNA alkylation damage repair as part of the ASCC-ALKBH3 complex 1. Pathogenic bi-allelic ASCC1 mutations cause spinal muscular atrophy with congenital bone fractures 2 (SMABF2), characterized by severe prenatal-onset muscle weakness, neonatal hypotonia, arthrogryposis, and congenital bone fractures 4. Loss of ASCC1 function impairs osteoblast differentiation while promoting adipogenesis through downregulation of RUNX2 and SERPINF1 and inhibition of TGF-Ξ²/SMAD signaling 5. ASCC1 polymorphisms are associated with osteoporosis and obesity risk in postmenopausal women 6. ASCC1 RNA overexpression correlates with poor survival in certain cancers and genetic instability 1.

Sources cited
1
ASCC1 structure contains KH and phosphodiesterase domains, germline mutations cause SMABF2, RNA overexpression correlates with poor cancer survival
PMID: 38750793
2
ASC-1 complex enhances NF-ΞΊB, SRF, and AP1 transactivation
PMID: 12077347
3
ASC-1 complex disassembles collided ribosomes in ATP-dependent, ubiquitination-dependent manner
PMID: 32579943
4
ASCC1 mutations cause severe muscle weakness, neonatal hypotonia, arthrogryposis, and congenital bone fractures
PMID: 30327447
5
ASCC1 loss impairs osteoblastogenesis, promotes adipogenesis, downregulates RUNX2 and SERPINF1, and inhibits TGF-Ξ²/SMAD signaling
PMID: 37455927
6
ASCC1 polymorphisms associated with osteoporosis and obesity in postmenopausal women
PMID: 32653958
Disease Associationsβ“˜22
spinal muscular atrophy with congenital bone fractures 2Open Targets
0.71Strong
spinal muscular atrophyOpen Targets
0.51Moderate
arthrogryposisOpen Targets
0.50Moderate
contractureOpen Targets
0.50Moderate
HypotoniaOpen Targets
0.50Moderate
Barrett's esophagusOpen Targets
0.48Moderate
genetic disorderOpen Targets
0.47Moderate
esophageal adenocarcinomaOpen Targets
0.45Moderate
fetal akinesia deformation sequenceOpen Targets
0.43Moderate
fetal akinesia deformation sequence 1Open Targets
0.43Moderate
prenatal-onset spinal muscular atrophy with congenital bone fracturesOpen Targets
0.37Weak
arthrogryposis multiplex congenitaOpen Targets
0.34Weak
centronuclear myopathyOpen Targets
0.34Weak
Alzheimer diseaseOpen Targets
0.28Weak
ovarian dysfunctionOpen Targets
0.28Weak
ArthropathyOpen Targets
0.21Weak
osteoarthritis, kneeOpen Targets
0.21Weak
neoplasmOpen Targets
0.11Weak
alcohol drinkingOpen Targets
0.10Weak
joint diseaseOpen Targets
0.08Suggestive
Barrett esophagusUniProt
Spinal muscular atrophy with congenital bone fractures 2UniProt
Pathogenic Variants30
NM_001198800.3(ASCC1):c.382C>T (p.Arg128Ter)Pathogenic
Spinal muscular atrophy with congenital bone fractures 2|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 128
NM_001198800.3(ASCC1):c.871+1G>APathogenic
not provided|Spinal muscular atrophy with congenital bone fractures 2
β˜…β˜…β˜†β˜†2025
NM_001198800.3(ASCC1):c.157dup (p.Glu53fs)Pathogenic
Spinal muscular atrophy with congenital bone fractures 2|not provided|See cases|ASCC1-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 53
NM_001198800.3(ASCC1):c.328C>T (p.Arg110Ter)Pathogenic
Spinal muscular atrophy with congenital bone fractures 2|not provided|Centronuclear myopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 110
NM_001198800.3(ASCC1):c.349C>T (p.Arg117Ter)Pathogenic
Spinal muscular atrophy with congenital bone fractures 2|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 117
NM_001198800.3(ASCC1):c.784C>T (p.Gln262Ter)Pathogenic
Spinal muscular atrophy with congenital bone fractures 2
β˜…β˜…β˜†β˜†2025β†’ Residue 262
NM_001198800.3(ASCC1):c.583C>T (p.Gln195Ter)Pathogenic
Spinal muscular atrophy with congenital bone fractures 2|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 195
NM_001198800.3(ASCC1):c.626+1G>APathogenic
Arthrogryposis multiplex congenita;Fetal akinesia deformation sequence 1|Fetal akinesia deformation sequence 1|Spinal muscular atrophy with congenital bone fractures 2|not provided
β˜…β˜…β˜†β˜†2024
NM_001198800.3(ASCC1):c.311-2A>GPathogenic
Inborn genetic diseases|Spinal muscular atrophy with congenital bone fractures 2|Squamous cell lung carcinoma
β˜…β˜…β˜†β˜†2021
NM_001198800.3(ASCC1):c.872-1G>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2026
NM_001198800.3(ASCC1):c.958-5483_958-5482insAAAAAAAAGGAAAAAAAAACATAGTATCTATTTCGTGGGGTTGTGAGGACGCAATAAGATAATTCCTGGCACATGTGTTTACTTAATAAATGTTGGCTGTTGTCATCTTTATTACTGTTGTTGTCAATACCTACATATTTCTAGTTCACTTTGATCTTTTTTTTGTTTTGTTTTGAGACAGAGCTTTGCCTTGTTGCCCAGGCTGGAGTACAATGAGCPathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_001198800.3(ASCC1):c.604C>T (p.Gln202Ter)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 202
NM_001198800.3(ASCC1):c.626+2T>ALikely pathogenic
Spinal muscular atrophy with congenital bone fractures 2
β˜…β˜†β˜†β˜†2024
NM_001198800.3(ASCC1):c.766C>T (p.Arg256Ter)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 256
NM_001198800.3(ASCC1):c.439C>T (p.Gln147Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 147
NM_001198800.3(ASCC1):c.411del (p.Ala138fs)Pathogenic
ASCC1-related disorder
β˜…β˜†β˜†β˜†2024β†’ Residue 138
NM_001198800.3(ASCC1):c.380_381del (p.Phe127fs)Likely pathogenic
Spinal muscular atrophy with congenital bone fractures 2
β˜…β˜†β˜†β˜†2023β†’ Residue 127
NM_001198800.3(ASCC1):c.464_465del (p.Glu155fs)Pathogenic
Spinal muscular atrophy with congenital bone fractures 2
β˜…β˜†β˜†β˜†2023β†’ Residue 155
NM_001198800.3(ASCC1):c.473T>C (p.Leu158Pro)Likely pathogenic
Spinal muscular atrophy with congenital bone fractures 2
β˜…β˜†β˜†β˜†2023β†’ Residue 158
NM_001198800.3(ASCC1):c.649del (p.Pro216_Leu217insTer)Likely pathogenic
ASCC1-related disorder
β˜…β˜†β˜†β˜†2022β†’ Residue 216
View on ClinVar β†—
Related Genes
MRPL13Protein interaction100%MRPL17Protein interaction100%MRPL21Protein interaction100%MRPL47Protein interaction100%MRPL46Protein interaction100%MRPL24Protein interaction100%
Tissue Expression6 tissues
Brain
100%
Heart
81%
Ovary
49%
Lung
42%
Liver
40%
Bone Marrow
19%
Gene Interaction Network
Click a node to explore
ASCC1MRPL13MRPL17MRPL21MRPL47MRPL46MRPL24
PROTEIN STRUCTURE
Preparing viewer…
PDB8TLY Β· 2.80 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.00LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.75 [0.56–1.00]
RankingsWhere ASCC1 stands among ~20K protein-coding genes
  • #6,963of 20,598
    Most Researched67
  • #1,809of 5,498
    Most Pathogenic Variants30
  • #9,693of 17,882
    Most Constrained (LOEUF)1.00
Genes detectedASCC1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
PMID: 34602496
J Neuromuscul Dis Β· 2022
1.00
2
ASCC1 structures and bioinformatics reveal a novel helix-clasp-helix RNA-binding motif linked to a two-histidine phosphodiesterase.
PMID: 38750793
J Biol Chem Β· 2024
0.90
3
The ASC-1 Complex Disassembles Collided Ribosomes.
PMID: 32579943
Mol Cell Β· 2020
0.80
4
Association between non-Caucasian-specific ASCC1 gene polymorphism and osteoporosis and obesity in Korean postmenopausal women.
PMID: 32653958
J Bone Miner Metab Β· 2020
0.70
5
Novel
PMID: 30327447
J Med Genet Β· 2019
0.60